BioCorRx (BICX) Net Cash Flow Growth (5y) (2015 - 2026)
BioCorRx (BICX) Net Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn |
| 10 | BioCorRx | 1.49 Mn | 1.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.00% |
| Dec 31, 2025 | 15.49% |
| Sep 30, 2025 | 18.46% |
| Jun 30, 2025 | 16.79% |
| Mar 31, 2025 | 37.59% |
| Dec 31, 2024 | 15.92% |
| Sep 30, 2024 | 63.18% |
| Jun 30, 2024 | -15.09% |
| Mar 31, 2024 | 16.41% |
| Dec 31, 2023 | -35.99% |
| Sep 30, 2023 | 34.20% |
| Jun 30, 2023 | -14.99% |
| Mar 31, 2023 | 74.47% |
| Dec 31, 2022 | 15.05% |
| Sep 30, 2022 | 38.87% |
| Jun 30, 2022 | 34.40% |
| Mar 31, 2022 | -39.65% |
| Dec 31, 2021 | -66.17% |
| Sep 30, 2021 | 15.31% |
| Jun 30, 2021 | -25.76% |